Abstract
Bioavailability, tissue distribution, blood concentration, and excretion of citrate-coated silver nanoparticles (AgNPs; size, 7.9 ± 0.95 nm by TEM diameter) were investigated. Male SD rats were treated by a single oral or intravenous administration of either 1 or 10 mg/kg AgNPs. Silver concentration of blood was determined at 10 min, and at 1, 2, 4, 8, 24, 48, and 96 h after treatment. Silver in the liver, lungs, and kidneys was also measured at 24 and 96 h after treatment. Excretion of silver nanoparticles via feces and urine was determined at 24 h after treatment. After oral administration, most AgNPs were found in feces, and their blood concentration was very low. This suggests that absorption through the gastrointestinal tract was not good. However, a high level of silver in the blood was detected after tail vein injection. When rats were injected with 1 mg/kg AgNPs, the silver concentration of blood was significantly elevated at 10 min after injection; the level subsequently decreased. In the rats treated with 10 mg/kg AgNPs, the elevated level did not decrease, but was maintained during the experimental period. On the basis of the values of AUCoral/AUCiv, the bioavailability of orally administered AgNPs was 1.2% in the group treated with 1 mg/kg AgNPs and 4.2% in the group treated with 10 mg/kg AgNPs. AgNPs accumulated in the liver, lungs, and kidneys; the accumulated AgNPs were released into the blood stream. AgNP levels in the urine were extremely low compared to the levels in the feces. When rats were injected with AgNPs, these particles were also detected in feces at 24 h after treatment, which suggests bile secretion of AgNPs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahamed, M., Karns, M., Goodson, M., Rowe, J., Hussain, S. M., Schlager, J. J., and Hong, Y., DNA damage response to different surface chemistry of silver nanoparticles in mammalian cell. Toxicol. Appl. Pharmacol., 233, 404–410 (2008).
Arora, S., Jain, J., Rajwade, J. M., and Paknikar, K. M., Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Appl. Pharmacol., 236, 310–318 (2009).
AshaRani, P. V., Low Kah Mun, G., Hande, M. P., and Valiyaveettil, S., Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano, 3, 279–290 (2009).
Braydich-Stolle, L., Hussain, S., Schlager, J. J., and Hofmann, M. C., In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci., 88, 412–419 (2005).
Carlson, C., Hussain, S. M., Schrand, A. M., Braydich-Stolle, L. K., Hess, K. L., Jones, R. L., and Schlager, J. J., Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B, 112, 13608–13619 (2008).
Chen, X. and Schluesener, H. J., Nanosilver: a nanoproduct in medical application. Toxicol. Lett., 176, 1–12 (2008).
Drake, P. L. and Hazelwood, K. J., Exposure-related health effects of silver and silver compounds: a review. Ann. Occup. Hyg., 49, 575–585 (2005).
Edwards-Jones, V., The benefits of silver in hygiene, personal care and healthcare. Lett. Appl. Microbiol., 49, 147–152 (2009).
Hsin, Y. H., Chen, C. F., Huang, S., Shih, T. S., Lai, P. S., and Chueh, P. J., The apoptotic effect of nanosilver is mediated by a ROS- and JNK- dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett., 179, 130–139 (2008).
Hyun, J. S., Lee, B. S., Ryu, H. Y., Sung, J. H., Chung, K. H., and Yu, I. J., Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicol. Lett., 182, 24–28 (2008).
Kim, W. Y., Kim, J., Park, J. D., Ryu, H. Y., and Yu, I. J., Histological study of gender differences in accumulation of silver nanoparticles in kidneys of Fischer 344 rats. J. Toxicol. Environ. Health A, 72(21–22), 1279–1284 (2009).
Kim, Y. S., Kim, J. S., Cho, H. S., Rha, D. S., Kim, J. M., Park, J. D., Choi, B. S., Lim, R., Chang, H. K., Chung, Y. H., Kwon, I. H., Jeong, J., Han, B. S., and Yu, I. J., Twenty-eight-day oral toxicity, genotoicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol., 20, 575–583 (2008).
Limbach, L. K., Wich, P., Manser, P., Grass, R. N., Bruinink, A., and Stark, W. J., Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol., 41, 4158–4163 (2007).
Lubick, N., Nanosilver toxicity: ions, nanoparticles — or both? Environ. Sci. Technol., 42, 8617 (2008).
Oberdörster, G., Oberdörster, E., and Oberdörster, J., Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 113, 823–839 (2005).
Park, E. J., Yi, J., Kim, Y., Choi, K., and Park, K., Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol. In Vitro, 24, 872–878 (2010).
Sharma, H. S., Hussain, S., Schlager, J., Ali, S. F., and Sharma, A., Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir. Suppl., 106, 359–364 (2010).
Sung, J. H., Ji, J. H., Park, J. D., Yoon, J. U., Kim, D. S., Jeon, K. S., Song, M. Y., Jeong, J., Han, B. S., Han, J. H., Chung, Y. H., Chang, H. K., Lee, J. H., Cho, M. H., Kelman, B. J., and Yu, I. J., Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci., 108, 452–461 (2009).
Tang, J. and Xi, T., Status of biological evaluation on silver nanoparticles. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 25, 958–961 (2008).
Tang, J., Xiong, L., Wang, S., Wang, J., Liu, L., Li, J., Yuan, F., and Xi, T., Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol., 9, 4924–4932 (2009).
Thrall, L., A nano Trojan horse. Environ. Sci. Technol., 41, 3791–3792 (2007).
Tóth, V., Marschalkó, M., Hársing, J., and Kárpáti, S., Grayish discoloration of the face-argyria. Orv. Hetil., 150, 1503–1507 (2009).
Zolgharnein, J., Hosseini, S., Azimi, G., and Sangi, M. R., Highly selective and efficient membrane transport of silver as AgBr2-ion using K+-decyl-18-crown-6 as carrier. Anal. Sci., 19, 871–875 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, K., Park, EJ., Chun, I.K. et al. Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats. Arch. Pharm. Res. 34, 153–158 (2011). https://doi.org/10.1007/s12272-011-0118-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0118-z